Your EHR can help you identify patients at risk for Pompe
A clinical decision support (CDS) notification will display during the patient visit if your patient’s medical history matches potential clinical markers of Pompe.
Pompe Disease: This patient has clinical markers that are considered at risk for Pompe Disease. Consider ordering a GAA enzyme activity assay to confirm the absence or presence of the diagnosis.
Citation: The Physician’s Guide to Pompe Disease (Glycogen Storage Disease, Type II; Acid Maltase Deficiency). National Organization for Rare Disorders (NORD)® Danbury, CT: Arnold J. J. Reuser, Ph.D., Paul H. Plotz, M.D., 2013.
Intervention Developer: Practice Fusion, Inc.
Funding Source: Sanofi Genzyme
Release Version: 1
Reference Information: https://rarediseases.org/physician-guide/pompe-disease/
You can adjust the display CDS notifications for Pompe disease at any time from the Notifications and Alerts section of your EHR settings.
Pompe testing is only available at select labs
Learn more about labs that offer GAA enzyme activity assays »